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Background
During the first trimester of pregnancy, Natural Killer cells
represent the main leukocyte population (70%) in the
human decidua (maternal uterine mucosa during preg-
nancy). These decidual NK cells (dNK) have a distinct
phenotype from their peripheral blood counterpart.
Decidual leukocyte populations contain also antigen-pre-
senting cells (dAPC) like dendritic cells and macrophages,
as well as regulatory and gamma-delta T cells.
In vitro, peripheral NK cells inhibit HIV-1 replication by
the release of chemokines or cytolytic activity. Further-
more, HIV-1 infected cells, through their altered-ligands-
expression, are able to trigger NK cell activation. As an
upregulation of NK cell activation has been reported in
exposed-non-infected individuals, we thus hypothesized
that dNK could play a role in the control of HIV-1 in utero
transmission by interacting with infected dAPC at the
materno-fetal interface.
Materials and methods
Deciduas were obtained from HIV-1 negative women
undergoing elective abortions between 6-10 weeks of
pregnancy. dNK cells and dAPC were isolated respectively
by negative and positive selection using Miltenyi
microbeads after collagenase digestion of the tissue. Cell
subpopulations were checked for purity and characterized
by FACS analysis using specific monoclonal antibodies.
Infections were performed in vitro with HIV-1 primary iso-
lates, HIV-1 strains carrying a GFP reporter gene or HIV-1
pseudotypes bearing a luciferase reporter gene. Decidual
histocultures were also performed and infected with the
same strain viruses.
Results
Phenotype of dNK was CD3−/CD16−/CD56high (up to
90%) and they expressed the activation markers CD69
(100%) and NKp44 (40%). Most of dNK expressed the
inhibitory receptor CD94/NKG2A but they expressed acti-
vating receptors including NKp46, NKp30, NKG2D and
CD94/NKG2C. The phenotypes of the main dAPC sub-
populations were CD14+/HLA-DR++/CD123+/− and a few
percentages were HLADR++/CD83low.
dNK cells were not permissive to HIV-1 infection in vitro,
even when they were pre-activated with IL-2. In contrast,
dAPC subpopulations as well as decidual histocultures
were susceptible to R5 and X4R5 HIV strains but not to X4
strains.
Conclusions
In decidual tissue, NK cells have a phenotype of activated
cells that might indicate their interaction with dAPC. The
infection of dAPC subpopulations by HIV-1 that we
observed in vitro might impact the cross-talk between
dAPC and dNK, especially through receptor and soluble
factor expression modifications. It is thus important to
further study the consequences of HIV-1 infection on dNK
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and dAPC interactions to gain new insights into the role
of these immune cells in controlling HIV-1 infection at
the materno-fetal interface.Page 2 of 2
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